answersLogoWhite

0

In dermatomyositis, the muscle weakness is accompanied by a rash that appears on the upper body, arms, and fingertips

User Avatar

Wiki User

14y ago

What else can I help you with?

Related Questions

What causes dermatomyositis?

The exact cause of dermatomyositis is unknown


Is Dermatomyositis rare?

Only about 20,000 people in the United States have dermatomyositis


How does Dermatomyositis cause death?

In about 5% of individuals the disease progresses to death because of heart and lung involvement


Why is polymyositis similar to dermatomyositis?

Dermatomyositis is identical to polymyositis with the addition of a characteristic skin rash.


When was dermatomyositis discovered?

The first cases of dermatomyositis were discovered by E. Wagner in 1863 and P. Potain in 1875.


Does dermatomyositis affect swallowing?

Yes, dermatomyositis can affect swallowing because it can cause muscle weakness and inflammation in the muscles of the throat and esophagus. This can lead to difficulty with swallowing, a condition known as dysphagia. It is important for individuals with dermatomyositis experiencing swallowing difficulties to seek assessment and treatment from healthcare providers.


What are other types of myopathy or inflammatory muscle disease?

Dermatomyositis (DM) and inclusion body myositis and juvenile dermatomyositis.


What drugs treat Dermatomyositis?

Prednisone and corticosteroids


How did Laurence olivier die?

Dermatomyositis - a muscle disorder.


Who discovered dermatomyositis?

Dermatomyositis was first described by Thomas Adolph Schweninger, a German doctor, in 1860. He observed the characteristic skin and muscle changes in patients with this condition.


How many people have dermatomyasitis disease?

The cause is largly unknown, however some science suggests that it can be cause by bacterial infections, or viruses. The focus is primarily on treatment of the symptoms and not the cause thereof.


Is Dermatomyositis fatal?

Dermatomyositis can be a serious condition but is not typically fatal on its own. However, complications related to the disease or its treatments may increase the risk of mortality. Close monitoring and appropriate management by healthcare providers are essential for individuals with dermatomyositis to help improve outcomes and quality of life.